AML patients with IDO-positive blasts were shown to have a higher frequency of circulating bona fide CD4+CD25+ Treg cells compared with patients harboring IDO-nonexpressing leukemia blasts. The gene discussed is IDO1; the disease is acute myeloid leukemia.